Rahul Yash

  Market Scope Market Research Future (MRFR) expects the bionic ear market share  should thrive at a rate of around 7.80% between 2022 and 2030. Major Growth Boosters and Impediments The alarming rise in the cases of hearing disorder across the globe, coupled with the burgeoning geriatric patient base with deteriorating hearing ability have been favorable for the global market. The World Health Organization (WHO) says that more than 570 million people across the world are affected by hearing disability. Hearing disorder generally develops in line with advancing age. Reports confirm that the condition affects nearly 80% of individuals that are over the age of 70. Prolonged exposure to loud noise, rising healthcare expenditure coupled with the emergence of sophisticated bionic ear devices would work in favor of the global industry as well. Significant demand for minimally or non-invasive surgeries is emerging as a major trend in the global market. The demand for bionic ear devic...

  Market Overview Cerebral vascular stents are small mesh-like tubes that are not coated or covered in any way. Stents are put into the brain arteries to treat brain aneurysms (a disorder in which the wall of a blood vessel weakens), intracranial stenosis, and to keep blood flowing through narrowed blood vessels. Brain stents are used to remove blood clots that have formed in the brain. During the projected period of 2022-2030, the cerebral vascular stent market share is expected to grow at a CAGR of 8.20%. Market Trends The rising prevalence of cerebral vascular disorders and the growing geriatric population are two main factors driving the cerebral vascular stent market. Furthermore, rising population awareness, increased development of bioresorbable stents, and a rise in the number of catheterization labs all contribute to market growth. The growing desire for minimally invasive surgeries has also aided the growth of this industry. When regulatory agencies approve the devices, ...

  Market Scope Market Research Future (MRFR) believes that the chlamydia infection treatment market share is expected that the growth rate of the market should be rich.   Primary Boosters and Deterrents Mounting patient knowledge backed by educational programs and campaigns coupled with the surge in government initiatives could be favorable for the chlamydia infection treatment market in the following years. Moreover, expanding population indulging in frequent unprotected casual sex and having multiple partners has also boosted the market demand. The global industry will also emerge lucrative in the years ahead on account of increasing use of technically advanced tools and products in the diagnostics field, which lead to more precise and accurate results. Additionally, the shift from conventional laboratory testing to the faster rapid point of care testing such as diagnostic kits, reagents, and instruments has also fostered the market share. The emergence of various governmen...

  Market Overview Market Research Future (MRFR) believes that the cell line development market share could surpass USD 6.15 billion by the end of the review period. MRFR also expects the global industry to expand at a rate of around 10.10% from 2022 to 2030. Primary Boosters and Challenges Several biopharma vendors make extensive use of cells, which work as expression hosts for the production of recombinant monoclonal antibodies. The mounting need for monoclonal antibodies and effective cancer therapeutics, along with the emergence and use of cutting-edge techniques for novel cell line production has resulted in considerable revenue generation in recent years. Moreover, surging focus on developing biosimilars due to patent expiry of established therapeutics and recombinant proteins will further push the market demand. Disconcerting rise in chronic diseases across the world has fostered the need for efficient and innovative treatment solutions, leading to significant requirement fo...

 Sleep apnea is a serious disorder, wherein breathing is interrupted for a brief or repeated period of time during sleep. Apnea means ‘no breath’ and sleep apnea causes a pause in breathing for at least ten seconds. Sleep apnea is divided into two types, obstructive and central sleep apnea. The former is caused due to a blockage of the upper airway. Whereas, the latter occurs when the brain is not able to properly control breathing during sleep. Untreated sleep apnea causes a person to experience repeated instances of pause in breathing during their sleep. In such cases, the brain and the rest of the body are not able to get enough oxygen intake. Sleep apnea devices are of immense importance in treating obstructive sleep apnea (OSA), a prevalent medical condition that affects a large number of people worldwide. The latest report revealed by Market Research Future (MRFR) reveals that the global sleep apnea devices market share to attain an anticipated CAGR figure of 6.52% during th...

  Market Highlights HERG Screening Market share is expected to register a CAGR of 12.50% during the assessment period of 2022 to 2030. HERG screening has played an important role as a component of cardiac safety pharmacology for the past many years. Over the years, major market players in the HERG screening market are focusing on various growth strategies such as product launches, product advancements, and expansions to cater to the growing needs. For instance, Eurofins Scientific announced the acquisition of DiscoverX, a leader in drug discovery products and services across all stages of discovery from target identification and led discovery to preclinical and beyond. Segment Analysis Global HERG Screening Market is segmented into Type, i.e., gene KCNH2 and mutant KCNH2. KCNH2 gene that provides guidelines for producing potassium channels and held the largest market share in the HERG screening market. The global HERG screening market is segmented based on ion channel, f...